x
|
Annual
report under Section 13 or 15 (d) of the Securities Exchange Act
of 1934
for the fiscal year ended December 31,
2004
|
o
|
Transition
report under Section 13 or 15 (d) of the Securities Exchange Act
of 1934
for the transition period from _____________to
_____________
|
Delaware
(State
or Other Jurisdiction of
Incorporation
or Organization)
|
20-0996152
(I.R.S.
Employer
Identification
No.)
|
|
3000
Sand Hill Road
Building
1, Suite 240
Menlo
Park, California
(Address
of Principal Executive Offices)
|
94025
(Zip
code)
|
December
31, 2004
|
||||
(Restated)
|
||||
ASSETS
|
||||
Current
assets:
|
||||
Cash
|
$
|
783,133
|
||
Treasury
bill held in trust
|
21,100,510
|
|||
Prepaid
expenses
|
132,131
|
|||
|
||||
Total
current assets
|
22,015,774
|
|||
|
||||
Total
Assets
|
$
|
22,015,774
|
||
|
||||
LIABILITIES
AND STOCKHOLDERS EQUITY
|
||||
Current
Liabilities:
|
||||
Accounts
payable and accrued expenses
|
$
|
15,772
|
||
|
||||
Total
Liabilities
|
15,772
|
|||
|
||||
Common
stock subject to possible conversion
(821,589 shares at conversion value) |
4,217,992
|
|||
Stockholders’
Equity:
|
||||
Preferred
stock, $0.01 par value
Authorized 5,000,000 shares; none issued |
—
|
|||
Common
stock, $0.01 par value
Authorized 50,000,000 shares Issued and outstanding, 5,110,000 shares |
51,100
|
|||
Additional
paid-in capital
|
17,780,817
|
|||
Deficit
accumulated during the development stage
|
(49,907
|
)
|
||
Total
Stockholders’ Equity
|
17,782,010
|
|||
Total
Liabilities and Stockholders’ Equity
|
$
|
22,015,774
|
Period
from
April
15, 2004
(inception)
to
December
31, 2004
|
||||
Formation
and operating costs
|
$
|
(191,946
|
)
|
|
Operating
loss
|
$
|
(191,946
|
)
|
|
Interest
income
|
142,039
|
|||
Net
loss
|
$
|
(49,907
|
)
|
|
Weighted
Average Shares Outstanding
|
3,468,784
|
|||
Net
Loss Per Share (Basic and Diluted)
|
$
|
(0.01
|
)
|
Period
from
April
15, 2004
(inception)
to
December
31, 2004
|
||||
CASH
FLOW FROM OPERATING ACTIVITIES
|
||||
Net
loss
|
$
|
(49,907
|
)
|
|
Accretion
of treasury bill
|
(75,510
|
)
|
||
Increase
in prepaid expenses
|
(132,131
|
)
|
||
Increase
in accounts payable and accrued expenses
|
15,772
|
|||
Compensation
expense related to issuance of Advisory Board options
|
2,447
|
|||
Net
cash provided by (used in) operating activities
|
(239,329
|
)
|
||
CASH
FLOW FROM INVESTING ACTIVITIES
|
||||
Purchase
of treasury bill in trust account
|
(21,025,000
|
)
|
||
Net
cash used in investing activities
|
(21,025,000
|
)
|
||
CASH
FLOW FROM FINANCING ACTIVITIES
|
||||
Proceeds
from sale of common stock to initial stockholders
|
25,000
|
|||
Gross
proceeds from public offering
|
24,660,000
|
|||
Costs
of public offering
|
(2,637,538
|
)
|
||
Proceeds
from stockholder loan
|
40,000
|
|||
Repayment
of stockholder loan
|
(40,000
|
)
|
||
Net
cash provided by financing activities
|
22,047,462
|
|||
NET
INCREASE IN CASH
|
783,133
|
|||
CASH
AT BEGINNING OF PERIOD
|
—
|
|||
CASH
AT END OF PERIOD
|
$
|
783,133
|
Shares
|
Amount
|
Additional
Paid-In
Capital
|
Deficit
Accumulated
During
Development
Stage
|
Total
|
||||||||||||
Balance,
April 15, 2004 (inception)
|
$
|
—
|
$
|
—
|
$
|
—
|
$
|
—
|
$
|
—
|
||||||
Sale
of 1,000,000 shares of common stock to initial stockholders at $0.025
per
share
|
1,000,000
|
$
|
10,000
|
$
|
15,000
|
$
|
25,000
|
|||||||||
Sale
of 3,600,000 shares of common stock to public stockholders at $6.00
per
share, net of offering expenses of $2,637,5538
|
3,600,000
|
$
|
36,000
|
$
|
18,926,462
|
$
|
18,962,462
|
|||||||||
Sale
pf 510,000 shares of common stock to underwriters at $6.00 per
share
|
510,00
|
$
|
5,100
|
$
|
3,054,900
|
$
|
3,060,00
|
|||||||||
Amortization
of Advisory Board Compensation
|
$
|
2,447
|
$
|
2,447
|
||||||||||||
Reduction
of capital related to the common stock subject to possible conversion
(821,589
shares at conversion value)
|
$
|
—
|
$
|
—
|
$
|
(4,202,898
|
)
|
$
|
—
|
$
|
(4,202,898
|
)
|
||||
Increase
in value of shares of common stock subject to possible
conversion
(821,589
shares at conversion value)
|
$
|
—
|
$
|
—
|
$
|
(15,094
|
)
|
$
|
—
|
$
|
(15,094
|
)
|
||||
Net
loss for the period April 15, 2004 (inception) to December 31,
2004
|
$
|
(49,907
|
)
|
$
|
(49,907
|
)
|
||||||||||
Balance,
December 31, 2004
|
$
|
5,100,000
|
$
|
51,100
|
$
|
17,780,817
|
$
|
(49,907
|
)
|
$
|
17,782,010
|
Shares
|
Weighted
Average
Exercise
Prices
|
Weighted
Average
Fair
Value
|
||||||||
Stock
options outstanding at April 15, 2004
|
—
|
$
|
—
|
$
|
—
|
|||||
Options
granted
|
60,000
|
4.75
|
.98
|
|||||||
Options
cancelled
|
—
|
—
|
—
|
|||||||
Stock
options outstanding at December 31, 2004
|
60,000
|
$
|
4.75
|
$
|
.98
|
|||||
Common
shares authorized under the 2004 Stock Plan
|
100,000
|
|||||||||
Outstanding
options
|
(60,000
|
)
|
||||||||
Outstanding
grants
|
—
|
|||||||||
Options
available for grant at December 31, 2004
|
40,000
|
|||||||||
Shares
exercisable at December 31, 2004
|
60,000
|
$
|
4.75
|